Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Editorial Office
- 30th Anniversary
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
12 October 2023
Current Oncology | Top Cited Papers in 2021 in the Section “Hematology”
As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Hematology” listed below:
1. “A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma”
by Elif Yilmaz, Arashpreet Chhina, Victor E. Nava and Anita Aggarwal
Curr. Oncol. 2021, 28(6), 5148–5154; https://doi.org/10.3390/curroncol28060431
Available online: https://www.mdpi.com/1718-7729/28/6/431
2. “Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?”
by Mitchell Sabloff, Steven Tisseverasinghe, Mustafa Ege Babadagli and Rajiv Samant
Curr. Oncol. 2021, 28(1), 903–917; https://doi.org/10.3390/curroncol28010089
Available online: https://www.mdpi.com/1718-7729/28/1/89
3. “How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen”
by José Cabeçadas, Victor E. Nava, Joao L. Ascensao and Maria Gomes da Silva
Curr. Oncol. 2021, 28(6), 4611–4633; https://doi.org/10.3390/curroncol28060390
Available online: https://www.mdpi.com/1718-7729/28/6/390
4. “Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor”
by Omar Alkharabsheh, Alhareth Alsayed, Diana M. Morlote and Amitkumar Mehta
Curr. Oncol. 2021, 28(1), 837–841; https://doi.org/10.3390/curroncol28010081
Available online: https://www.mdpi.com/1718-7729/28/1/81
5. “Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada”
by Jean Lachaine, Catherine Beauchemin, Kimberly Guinan, Philippe Thebault, Andrew Aw, Versha Banerji, Isabelle Fleury and Carolyn Owen
Curr. Oncol. 2021, 28(1), 332–345; https://doi.org/10.3390/curroncol28010037
Available online: https://www.mdpi.com/1718-7729/28/1/37
6. “Spinal Manifestation of Malignant Primary (PLB) and Secondary Bone Lymphoma (SLB)”
by Melanie Barz, Kaywan Aftahy, Insa Janssen, Yu-Mi Ryang, Georg Prokop, Stephanie E. Combs, Philipp J. Jost, Bernhard Meyer and Jens Gempt
Curr. Oncol. 2021, 28(5), 3891–3899; https://doi.org/10.3390/curroncol28050332
Available online: https://www.mdpi.com/1718-7729/28/5/332
7. “The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry”
by Chris Varghese, Tracey Immanuel, Anna Ruskova, Edward Theakston and Maggie L. Kalev-Zylinska
Curr. Oncol. 2021, 28(2), 1544–1557; https://doi.org/10.3390/curroncol28020146
Available online: https://www.mdpi.com/1718-7729/28/2/146
8. “Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma”
by Rami Abdulbaki, Parastou Tizro, Victor E. Nava, Maria Gomes da Silva and João L. Ascensão
Curr. Oncol. 2021, 28(6), 4821–4831; https://doi.org/10.3390/curroncol28060407
Available online: https://www.mdpi.com/1718-7729/28/6/407